Percheron Therapeutics Ltd (PER) — Cash Flow Quality Index
Percheron Therapeutics Ltd (PER) has a Cash Flow Quality Index of -0.84x as of June 2025. Operating cash flow of AU$-7.16 Million is below net income of AU$8.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Percheron Therapeutics Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Percheron Therapeutics Ltd Cash Flow Quality Index (2015–2015)
Historical Cash Flow Quality Index for Percheron Therapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Percheron Therapeutics Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Percheron Therapeutics Ltd (2015–2015)
Year-by-year earnings quality comparison for Percheron Therapeutics Ltd. For live market cap and the full company financial profile, see market cap of Percheron Therapeutics Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2015 | 1.79x | AU$1.27 Million | AU$706.92K | — |